SSTR2 and prostate carcinoma: On the contrary to the observation of high levels of SSTR2 in prostate cancer tissue, Halmos et al. investigated 22 human prostate tissue samples, using RT-PCR, for mRNA expression and reported a detection rate of 86% for SSTR1 and 64% for SSTR5.